Sugi Predict

Sugi Predict / Targets / LANCL1

LANCL1

Glutathione S-transferase LANCL1 · O43813 · LANCL1 on Sugi Atlas →

0 patent compounds predicted against LANCL1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LANCL1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cysteine Supplementation in Critically Ill Neonates PHASE2/PHASE3UNKNOWN
Tolerability of Enteral NAC in Infants PHASE1NOT_YET_RECRUITING
The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels PHASE1COMPLETED
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS nanRECRUITING
Longitudinal Study of the Porphyrias nanRECRUITING
Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney Disease nanUNKNOWN
Review of French Cases of Glutathione Synthetase Deficiency nanUNKNOWN
Genetics of Familial Testicular Cancer nanCOMPLETED
Genetic Variants and Regulation of Specialized Pro-resolving Mediator nanRECRUITING
Genetics of Familial and Sporadic ALS nanCOMPLETED
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
Using Next-generation Sequencing in the Diagnosis of Epilepsy and/or Intellectual Disability in a Pediatric Cohorte nanCOMPLETED
Effect of Sulfur Amino Acid Depletion and Acetaminophen on Plasma Glutatione nanCOMPLETED
Epidemiology of Atherosclerosis nanCOMPLETED
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study nanCOMPLETED
Pharmacogenomic Response to Thyrotropin-Releasing Hormone Stimulation in Healthy Volunteers: The Influence of a Common Type 2 Deiodinase Genetic Polymorphism on Serum T3 nanCOMPLETED
Genetic Epidemiology of Asthma in Costa Rica nanCOMPLETED
Exome Evaluation in Patients Living With Diabetes Complicated by Charcot Neuroarthropathy. nanCOMPLETED
Genetic Analysis of Parkinson's Disease nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis nanNOT_YET_RECRUITING
External Nitric Oxide Measurement Through SNO Degradation nanENROLLING_BY_INVITATION
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism nanACTIVE_NOT_RECRUITING
Lipa Gene Mutation in PED-LIPIGEN (Pediatric FH Subjects) nanUNKNOWN
Clubfoot DNA Repository nanCOMPLETED
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING
Gene Expression in Obesity and Insulin Resistance nanCOMPLETED
Plant-based Diets and Body Weight and Selected Metabolic Parameters Management in Obese Patients. nanCOMPLETED
Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children nanWITHDRAWN
The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in Diabetes nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LANCL1 binder may also engage these)

ProteinNameSimilarity
F1MVX2 — 1.000 F1MVX2 →
O89112 — 1.000 O89112 →
Q9QX69 — 1.000 Q9QX69 →
Q90ZL2 — 0.999 Q90ZL2 →
LANCL2 LanC-like protein 2 0.994 landscape →
Q9JJK2 — 0.994 Q9JJK2 →
Q9Y0Y7 — 0.993 Q9Y0Y7 →
Q29HZ1 — 0.992 Q29HZ1 →
F4IEM5 — 0.988 F4IEM5 →
Q8VZQ6 — 0.981 Q8VZQ6 →
Q9FJN7 — 0.977 Q9FJN7 →
P56523 — 0.975 P56523 →
Q503L4 — 0.974 Q503L4 →
Q8VYB2 — 0.974 Q8VYB2 →
Q2KNB7 — 0.973 Q2KNB7 →
Q16P90 — 0.973 Q16P90 →
Q4R8B6 — 0.973 Q4R8B6 →
Q8R2W9 — 0.973 Q8R2W9 →
Q80VY9 — 0.973 Q80VY9 →
O65583 — 0.973 O65583 →
B9KHF1 — 0.973 B9KHF1 →
Q9FI37 — 0.972 Q9FI37 →
Q8K2I1 — 0.972 Q8K2I1 →
Q8BFV2 — 0.972 Q8BFV2 →
Q5GTB4 — 0.972 Q5GTB4 →
Q09266 — 0.972 Q09266 →
Q28D40 — 0.972 Q28D40 →
Q68EH8 — 0.972 Q68EH8 →
Q5U3P0 — 0.972 Q5U3P0 →
Q28DB0 — 0.972 Q28DB0 →